🔎 Trials Near Me

Beranda › Penyakit Radang Usus › Illinois

Uji klinis Penyakit Radang Usus di Illinois

7 studi untuk Penyakit Radang Usus mencari peserta di lokasi di Illinois.

Kota di Illinois

Teks studi resmi (Bahasa Inggris)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Northwestern University, Chicago
  • Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 038, Chicago
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-005, Des Plaines
  • Site US-007, Glenview
  • Site US-020, Gurnee
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487

A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

  • Northwest Gastroenterologist, Glenview
Menerima pesertaFase 4
3 Weeks · Wanita · Diperbarui 8 Sep 2026 · NCT07612267

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

  • Rush University Medical Center, Chicago
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05579392

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Glenview
  • Mirador Therapeutics Selected Site, Gurnee
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

  • University of Chicago Medical Center, Chicago
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT01280825

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.